India to boost production of combat medicines, pharma dept told to prepare list of drugs
The Department of Pharmaceuticals has been tasked to come up with a list of such medicines and ensure an increase in their production to mitigate health risk from the ongoing conflict with Pakistan.
Also Read | Health emergency plan introduced for J&K, portable hospitals in Poonch, Uri
The top drug price regulator—National Pharmaceutical Price Regulator (NPPA)—has been directed by the Centre to ensure that the prices of such pharmaceutical items are brought under control.
'The department of pharmaceuticals along with the National Health Systems Resource Centre (NHSRC) is preparing a list of all such medicines used for the treatment of trauma and burn injury, bullet injury and wound etc, so that the production of such pharmaceutical items can be augmented in the country to deal with any health emergency, if needed," said an official familiar with the matter.
Also Read | E-pharmacies, chemists at odds as govt mulls a stop to home delivery of drugs
A decision to this effect was taken at a meeting chaired by the union health minister J.P. Nadda on Friday to review the preparedness of the health sector.
In a war-like situation, health expenditure significantly goes up due to higher demand for medical care, particularly for combat-related injuries and the mental health impacts of conflict.
Medicines and surgical equipment like painkillers, antibiotics, gauges, orthopedic implants, blood replenishers among other products are used for the treatment of trauma injuries, bullet or gunshot wounds, etc.
Also Read | India should permit easier access to over-the-counter medicines
The official added that the top drug regulator has been tasked to review the companies which are manufacturing such products so that they can be and directed to increase the production of such items. 'Similarly, the NPPA has to ensure the price control of these pharmaceutical items."
During the meeting, the government the reviewed the medical preparedness for handling emergency cases, deployment of ambulances; ensuring adequate availability of medical supplies including equipment, medicines, supply of blood vials and consumables; hospital readiness in terms of beds, ICU and HDU; deployment of BHISHM (Bharat Health Initiative for Sahyog, Hita and Maitri) Cubes, advanced mobile trauma care units etc.
'A 24*7 control and command centre is being set up in the health ministry to monitor ongoing efforts and support states in the present times and fulfil the requirements of the state/UT governments," the official said.
A senior doctor from the burns and plastic department at a government hospital said, 'We are ready to tackle any health crisis and we have adequate number of beds, medical supplies etc. In the event of trauma injury or gun shot injury, medicines like painkillers, antibiotics and requirements of blood get increased."
Dr Mahesh Mangal, head of plastic surgery department at Sir Ganga Ram Hospital, said that main war-related injuries are caused by blasts and burns. "A hospital's trauma team comprising plastic surgeons, orthopedic surgeon, neuro surgeon, general surgeon etc, should be capable of saving the life of the patient. Requirement of combat medicine increases during this time—which are life-saving drugs, blood and blood products, fluids, dressings, oxygen, antibiotics and painkillers."
Queries sent to the health ministry spokesperson remained unanswered.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
9 hours ago
- The Hindu
A new BHARAT- establishing baseline health parameters for the Indian population
We don't all age the same way, but we all do age. We intuitively recognise frailty when things start to slow down. Ageing unfolds at different rates, over time, between individuals, within and across populations. Often, it happens in bursts. Ageing is complicated. It is driven by molecular and cellular interactions and is shaped by one's environment, lifestyle, and socioeconomic conditions. This means one's chronological age often doesn't reflect how old one's body really is. Since researchers discovered in 1935 that ageing can be altered, they have been looking for reliable biological clues, called biomarkers, that in isolation or together can indicate how old our bodies are and how they might respond to factors such as diet, exercise, etc. Biomarkers of ageing Last year, the Indian Institute of Science (IISc), Bengaluru, launched a large-scale study called BHARAT, short for 'Biomarkers of Healthy Aging, Resilience, Adversity, and Transitions', as part of its Longevity India Program. The study aims to map the physiological, molecular, and environmental indicators that drive ageing in the Indian population. 'We lack clear information on what features define or influence healthy ageing,' says Deepak Kumar Saini, convener of BHARAT and professor of development biology and genetics at IISc. 'We are building an information portal to understand the rules of healthy ageing in Indians.' Worldwide, life expectancy has risen significantly over the past few decades. In India it climbed 4.1 years to 67.3 in the first two decades of this century. Living longer doesn't mean living healthier, however. Studies have predicted a 168% increase in Parkinson's disease cases in India by 2050 and a 200% rise in dementia across low- and middle-income countries. Yet much of what we know about health and disease risk comes from studies in Western populations, which means the diagnostic tools, biomarkers, and even treatments may not be optimal for people in India or other non-Western countries. Gaps for patients in Global South This limited focus has created a gap between population-based biomarkers and diagnostic cut-offs for people in the Global South. This can lead to misdiagnosis and treatments that don't reflect how diseases progress or respond to therapeutics in different groups. 'Western values for cholesterol, vitamin D, or B12 may label many Indians as deficient. But are these truly abnormal within our context? Our study aims to answer that. We are not only identifying biomarkers for healthy ageing but also building the Bharat Baseline — a reliable reference for what is normal in the Indian population,' Prof. Saini says. Earlier this year, researchers from Sichuan, China, reported in Scientific Reports that certain biomarkers for breast cancer, such as high levels of high-density lipoprotein cholesterol, could signal an elevated risk in European populations but may serve as supportive indicators in Asians. 'We see differences in inflammatory markers. For instance, C-reactive protein (CRP) levels tend to be elevated in Indians even without acute illness. This inflammation often results from early-life infections, environmental toxins, or chronic nutritional and metabolic issues,' Shawn T. Joseph, senior consultant, head and neck surgical oncology, VPS Lakeshore Hospital in Kochi, says. 'Applying Western CRP cut-offs risks missing early warning signs of cardiovascular or metabolic disease in Indian patients,' he adds. An India-specific database BHARAT's goal is to change this. Its database will include genomic biomarkers (like mutations linked to disease susceptibility), proteomic and metabolic indicators (reflecting biological pathways and metabolic health), and environmental and lifestyle factors. Identifying early warning signs of age-related changes can enable better prediction, intervention, and potentially delay the onset of disease. There is a need for proactive markers of health, indicators that can tell when an organ is functioning below its optimal level, even if it is not yet diseased. For instance, your liver age is more than your chronological age. To do that, researchers must sift through large, many-dimensional datasets and plan to take the help of artificial intelligence (AI) models. 'AI and machine learning are essential to integrate and analyse layered data to see the full picture. It can simulate the impact of interventions and augment existing datasets to improve signal detection that may otherwise be missed in high-dimensional, small-sample studies. This will help us choose the most effective interventions before launching costly trials,' says Tavpritesh Sethi, professor of computational biology at the Indraprastha Institute of Information Technology, Delhi, who is also one of the investigators of BHARAT. However, if the AI models' training datasets don't reflect local realities, they risk perpetuating health inequities. India's population is genetically, environmentally, and socioeconomically diverse. Capturing this diversity in a single database is crucial but also logistically complex. Prof Saini anticipates a few challenges, including the difficulty of obtaining samples from healthy adults, securing long-term government and philanthropic funding, and expanding the study to collect samples from across the country. (Rupsy Khurana is science communication and outreach lead at the National Centre for Biological Sciences, Bengaluru.
Time of India
5 days ago
- Time of India
Crackdown on hosps charging Ayushman beneficiaries
Varanasi: Taking a serious note of increasing complaints from Ayushman card holders that they were charged the treatment cost by listed hospitals, the district administration directed officials of these hospitals to either return the money charged from beneficiaries or be ready to face stern action. As many as 26 beneficiaries have filed complaints for being charged money despite having Ayushman cards. In view of the complaints lodged by Ayushman beneficiaries against hospitals listed under the Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana, chief development officer (CDO) Himanshu Nagpal convened a meeting on Saturday evening. He made it clear that as all beneficiaries are eligible to receive free treatment as per rules and if any expenses have been charged from them during treatment by any hospital, it should be reimbursed immediately. Punitive action would follow in case they do not follow the directives, he said. The CDO added if any hospital is found involved in charging extra money from an Ayushman beneficiary, its association with the scheme would be revoked by notifying senior officials at the State Agency for Health and Integrated Services (SACHIS), while their registration would also be cancelled. Last year, 26 Ayushman card holders lodged complaints against a few hospitals accusing them of charging the treatment cost. Health officials informed the CDO that of the 26 complainants, the money of 20 has been reimbursed so far. Three cases are still being processed and three have been sent to SACHIS. Complaints against at least three hospitals have been forwarded to the state-level controlling authority (SACHIS) for action, said officials. The CDO emphasized that patients visiting listed hospitals must provide a consent form indicating if they hold an Ayushman card, which should be verified using their Aadhaar card on the portal. All affiliated hospitals should update and inform the office about the information, education and communication (IEC) material, help desks and kiosks related to the Ayushman Bharat scheme. The help desk should display the presence of an Ayushman Mitra along with their phone numbers as well as the phone numbers of the hospital. In compliance with Section 28 (Display of Information) of the UP Clinical Establishment (Registration and Regulation) Rules 2016, hospitals should display the specialty registration number, director's name, bed count, method of treatment and services provided along with details of medical staff (doctors, nurses, etc.) on a display board with a yellow background and black Hindi letters. This board should be placed near the hospital's main entrance and a complaint box should also be installed there. Chief Medical Officer Dr Sandeep Chaudhary stated that requests to revoke claims cancelled by contracted hospitals more than six months ago will not be considered as per SACHIS instructions. Hospitals can submit an appeal to the State Grievance Redressal Committee (SGRC) within 30 days if dissatisfied with decisions made on claim forms presented at the district grievance redressal committee meeting. Additional CMOs, including Dr SS Kannaujia, Dr Piyush Rai, and representatives of the hospitals concerned, were present at the meeting.
The Hindu
6 days ago
- The Hindu
Centre approves 300-bed polytrauma centre at NIMHANS north campus in Bengaluru
The Central government has approved the establishment of a 300-bed Polytrauma Centre and Postgraduate Institute at Kyalasanahalli in Bengaluru North, where the north campus of NIMHANS is coming up. The project to be taken up at a cost of ₹498 crore was awaiting approval for the last 11 years. In July last year, C.N. Manjunath, Bengaluru Rural MP, had submitted a concept note on the proposal for the 300-bed polytrauma centre to the Union Health Minister J.P. Nadda, urging him to accord sanction at the earliest. According to the sanction letter dated June 27 by the Union Ministry of Finance, the Union Health Ministry should ensure optimisation of resources (manpower, infrastructure, supplies and medicines) as suggested by NITI Aayog in 2021, in its report titled 'Emergency and Injury Care at Secondary and Tertiary level Centres in India'. 'To optimise the resources of the polytrauma centre, the proposed facility should also cater to regular patients along with emergency cases,' the letter stated. Golden hour requirement 'Given that nearly 15% of deaths in India are due to road accidents and about 30% of accident victims suffer from multiple injuries, the need for a dedicated trauma facility is urgent. The ability to provide comprehensive, immediate care under one roof during the 'Golden Hour' can significantly improve survival rates and recovery outcomes,' he said. Pointing out that the polytrauma centre will serve as a crucial facility for the treatment of patients suffering from multiple and complex injuries, including those involving the head, brain, chest, abdomen and bones, the doctor-turned-politician said the Centre will play a vital role in addressing the growing shortage of hospital beds in Karnataka, especially in Bengaluru, and will ensure faster, more efficient trauma care. Importantly, it will also include a postgraduate institute to train trauma care specialists. NIMHANS overcrowded 'The outpatient footfall at NIMHANS, the country's premier mental health institution, has increased from around 250 patients a day to 2,500 a day now. The hospital is always overcrowded and not able to cope with the load of patients. Because of space constraints and the non-availability of polytrauma services, critical patients are shifted from NIMHANS to other hospitals. Some of them die during transit,' he said. 'This will be the second polytrauma centre in India, after the Jayaprakash Narayan Apex Trauma Centre at AIIMS, New Delhi, marking a significant expansion of India's trauma care infrastructure. Construction is set to be completed in 30 months,' Dr. Manjunath said. Although the State government had allotted 37 acres of land, and the above proposal has been approved by the governing body of the institution with many revisions and re-revisions, it was pending for almost 11 years, he said.
